acetaminophen pm
- Product NDC
- 41163-515
- 11-digit product format
- 411630515
- Labeler code
- 41163
- Product ID
- 41163-515_24b11c3b-9c19-ff00-e063-6394a90adbed
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- United Natural Foods, Inc. dba UNFI
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-09-01
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 500; 25 mg/1; mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41163-515 | 41163-515-02 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 41163-515 | 41163-515-14 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41163-515-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41163-515-14 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41163-515-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41163-515-14 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41163-515-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41163-515-14 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41163-515-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41163-515-14 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41163-515-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41163-515-14 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41163-515-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41163-515-14 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41163-515-02 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41163-515-14 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41163-515-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41163-515-14 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41163-515-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41163-515-14 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41163-515-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41163-515-14 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41163-515-14 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41163-515-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41163-515-14 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41163-515-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acetaminophen pm
- Brand name suffix
- extra strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
| DIPHENHYDRAMINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1092189 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f86a11af-6d3c-4638-870d-a663ddf49371 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41163-515-01 | acetaminophen pmextra strength | 1 in 1 CARTON | TABLET, COATED | 1 | 10 | |
| 41163-515-01 | acetaminophen pmextra strength | 24 in 1 BOTTLE, PLASTIC | TABLET, COATED | 24 | 10 | |
| 41163-515-02 | acetaminophen pmextra strength | 50 in 1 BOTTLE, PLASTIC | TABLET, COATED | 50 | 10 | |
| 41163-515-02 | acetaminophen pmextra strength | 1 in 1 CARTON | TABLET, COATED | 1 | 10 | |
| 41163-515-03 | acetaminophen pmextra strength | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 10 | |
| 41163-515-03 | acetaminophen pmextra strength | 1 in 1 CARTON | TABLET, COATED | 1 | 10 | |
| 41163-515-14 | acetaminophen pmextra strength | 200 in 1 BOTTLE, PLASTIC | TABLET, COATED | 200 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41163-515-01 | EA - Each | 41163-515 | 5c6c8447-ffdb-4a36-ad82-f857e36fb2a5 | 1 | 2016-10-06 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41163-515 | ACETAMINOPHEN PM EXTRA STRENGTH (ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE) TABLET, COATED [UNITED NATURAL FOODS, INC. DBA UNFI] | 10 | Current NDC, Legacy NDC, 7 package rows | 20241019_f86a11af-6d3c-4638-870d-a663ddf49371.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INFANTS PAIN AND FEVER | ACETAMINOPHEN | Amazon.com Services LLC | 112076c4-cac2-45ab-9c77-5573edae7180 | 2026-07-10 | Warnings | M013 |
| Aspirin | ASPIRIN | Wal-Mart Stores Inc | 8ae16aa2-54bc-4c1a-aa36-93524199a67b | 2026-07-09 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Wildman Business Group | 943c8f49-e65e-40bc-b364-3274df4d21a2 | 2026-07-09 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN | FOODHOLD U.S.A., LLC | 9e09b4fb-e015-45ea-8b1c-27faf65572aa | 2026-07-09 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | Walgreen Company | f13fb7e9-50ea-4e2c-a442-38b1b5b315d7 | 2026-07-09 | Warnings | M013 |
| Acetaminophen 500 Pyrilamine Maleate 15 and Caffeine 60 | ACETAMINOPHEN 500MG PYRILAMINE MALEATE 15MG AND CAFFEINE 60MG TABLETS | Health Pharma USA LLC | 34eb8a9b-d0ee-13e8-e063-6294a90a2fef | 2026-07-08 | Warnings | M013 |
| Acetaminophen 250 mg Aspirin 250 mg Caffeine 65 mg | ACETAMINOPHEN 250 MG ASPIRIN 250 MG CAFFEINE 65 MG | Health Pharma USA LLC | 3590d417-272b-ae4d-e063-6394a90a5dc6 | 2026-07-08 | Warnings | M013 |
| GOODMEDS EXTRA STRENGTH PAIN RELIEF ACETAMINOPHEN | ACETAMINOPHEN | Cabinet Health P.B.C. | 88884253-5a79-4ac1-b8ce-03966d8b509d | 2026-07-08 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Health Pharma USA LLC | 671adabe-5f82-4599-a133-3f67ccb34079 | 2026-07-07 | Warnings | M013 |
| Pain Reliever Plus | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Rugby Laboratories | c3df1652-96a8-6043-e053-2995a90a2d26 | 2026-07-07 | Warnings | M013 |
| Rapidol Aspirin | ASPIRIN | Pharmadel LLC | 00d9ab0d-ff25-784f-e063-6294a90a8497 | 2026-07-06 | Warnings | M013 |
| Aspirin | ASPIRIN | Trifecta Pharmaceuticals USA LLC | 227cefca-acc4-41d0-e063-6394a90a35b9 | 2026-07-06 | Warnings | M013 |
| Extra Strength Pain Aid | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Hi-Tech Nutaceuticals, LLC | a39e4b99-700d-0f5c-e053-2a95a90a6bd3 | 2026-07-06 | Warnings | M013 |
| Nighttime Sleep Aid | ACETAMINOPHEN, DIPHENHYDRAMINE | Hi-Tech Nutraceuticals, LLC | a39e2bd6-3d0a-642b-e053-2995a90a42a0 | 2026-07-06 | Warnings | M013 |
| Extra Strength Acetaminophen | ACETAMINOPHEN | Hi-Tech Nutraceuticals, LLC | a36be487-7a36-550f-e053-2a95a90a95c1 | 2026-07-06 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Hi-Tech Nutraceuticals, LLC | a39c524e-c131-d7fb-e053-2995a90a785b | 2026-07-06 | Warnings | M013 |
| PAIN RELIEVER | ASPIRIN 81 MG | Health Pharma USA, LLC | d60aed37-3a9e-46d1-e053-2995a90a1d1f | 2026-07-06 | Warnings | M013 |
| Tylenol PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Select Consumer Group | 55d0dceb-c9a9-778e-e063-6294a90a2ad7 | 2026-07-04 | Warnings | M013 |
| Bayer Genuine Aspirin | ASPIRIN | Select Consumer Group | 3ca776c2-47ed-5107-e063-6394a90ac5df | 2026-07-03 | Warnings | M013 |
| Aspirin | ASPIRIN | Rugby Laboratories | f7ca9f4a-f8ef-46d2-9536-b69541e6653d | 2026-07-02 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1092189 | acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet | PSN | f86a11af-6d3c-4638-870d-a663ddf49371 | 10 |
| 1092189 | acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet | SCD | f86a11af-6d3c-4638-870d-a663ddf49371 | 10 |
| 1092189 | APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet | SY | f86a11af-6d3c-4638-870d-a663ddf49371 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 41163-515-01 | 41163051501 | 1 BOTTLE, PLASTIC in 1 CARTON (41163-515-01) / 24 TABLET, COATED in 1 BOTTLE, PLASTIC | 2014-09-01 | 0000-00-00 | No | No | Current |
| 41163-515-02 | 41163051502 | 50 in 1 BOTTLE, PLASTIC | Historical | ||||
| 41163-515-03 | 41163051503 | 1 BOTTLE, PLASTIC in 1 CARTON (41163-515-03) / 100 TABLET, COATED in 1 BOTTLE, PLASTIC | 2014-09-01 | 0000-00-00 | No | No | Current |
| 41163-515-14 | 41163051514 | 200 in 1 BOTTLE, PLASTIC | Historical |